Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Single Arm, Non-interventional, Prospective Study to Assess Demographic Characteristics and Patient Reported Outcomes in Patients With Severe Eosinophilic Asthma Treated With Benralizumab in China

NCT06862206 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06862206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06862206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Single Arm, Non-interventional, Prospective Study to Assess Demographic Characteristics and Patient Reported Outcomes in Patients With Severe Eosinophilic Asthma Treated With Benralizumab in China
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
July 11, 2025
Completion date
January 30, 2028
Enrollment
1,000 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease